DWP-450 (Nabota)

botulinum toxin type A · Daewoong Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DWP-450 (Nabota), covering 2018-05-07 to 2018-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity [Phase 4]